UOTTAIMCU
SAGE

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Sage Therapeutics SAGE Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-13,018
Closed -$551K – 36
2015
Q3 		$551K Buy
+13,018
New +$802K 0.27% 13

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s SAGE Position: Q4 2015 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of Sage Therapeutics (SAGE) in Q4 2015, closing a stake of 13,018 shares — an estimated $551K sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in SAGE in Q3 2015 and held it in 1 quarter. The position peaked at $551K in Q3 2015. 138 funds tracked by Wall St. Rank hold SAGE as of Q4 2015.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining Sage Therapeutics position as of Q4 2015 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 13,018 Sage Therapeutics shares in Q4 2015, an estimated $551K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Sage Therapeutics in Q3 2015 and held it in 1 quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Sage Therapeutics position peaked at $551K in Q3 2015.
  • 138 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2015.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q4 2015, filed 5 Feb 2016.